In the same study, a DC gene signature (including XCR1, BATF3, FLT3, and IRF8) expression correlated with increased survival of patients treated with PD-L1 blockade in NSCLC and renal cell carcinoma (61). The gene discussed is CD274; the disease is non-small cell lung carcinoma.